Outset Medical (OM) Liabilities and Shareholders Equity (2019 - 2026)

Outset Medical (OM) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $249.5 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 17.18% year-over-year to $249.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 8.82% YoY) and the FY2025 annual result came in at $264.5 million, down 4.1% from the prior year.
• Liabilities and Shareholders Equity retreated to $249.5 million in Q1 2026 per OM's latest filing, from $264.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $431.7 million in Q1 2022 and bottomed at $249.5 million in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $313.8 million (2023), against an average of $325.2 million.
• Peak annual rise in Liabilities and Shareholders Equity reached 13.67% in 2022, while the deepest fall reached 25.18% in 2022.
• Tracing OM's Liabilities and Shareholders Equity over 5 years: stood at $400.1 million in 2022, then fell by 21.57% to $313.8 million in 2023, then slipped by 12.11% to $275.8 million in 2024, then fell by 4.1% to $264.5 million in 2025, then slipped by 5.69% to $249.5 million in 2026.
• Per Business Quant, the three latest OM Liabilities and Shareholders Equity figures stand at $249.5 million (Q1 2026), $264.5 million (Q4 2025), and $277.3 million (Q3 2025).

Peer Comparison